AI assistant
Sending…
RESMED INC — Director's Dealing 2012
Apr 4, 2012
30071_dirs_2012-04-04_497a4ded-804e-4d34-9dbc-aa04295d0f56.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-04-02
Reporting Person: FARRELL PETER C (Director, Executive Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-04-02 | ResMed Common Stock | G | 3317 | — | Disposed | 330276 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 0 | Indirect |
| ResMed Common Stock | 21391 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
Footnotes
F1: Transaction represents a gift from the Peter C. Farrell April 2010 Annuity Trust (the "Trust")to the Peter C. Farrell Trust. Per the terms of the Trust, the remaing 10% of the original value of the Trust is to be distributed to the Peter C. Farrell Trust at the end of the second year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29